Sernova (TSE:SVA) Stock Price Up 2.9% - Still a Buy?

Sernova Corp. (TSE:SVA - Get Free Report)'s stock price shot up 2.9% during mid-day trading on Tuesday . The company traded as high as C$0.18 and last traded at C$0.18. 396,898 shares traded hands during trading, an increase of 184% from the average session volume of 139,860 shares. The stock had previously closed at C$0.17.

Sernova Stock Performance

The company has a 50 day simple moving average of C$0.17 and a 200 day simple moving average of C$0.19. The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of -4.40. The stock has a market cap of C$58.89 million, a price-to-earnings ratio of -1.69 and a beta of 1.35.

Sernova Company Profile

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.